Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-26

Clinical Trial Update: Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients

View source ↗

Summary

A completed clinical trial comparing fecal and oral microbiota profiles between pancreatic cancer patients and those with benign or low-grade pancreatic tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Microbiome, Pancreatic Neoplasms | Status: COMPLETED